Continuous treatment with odanacatib for up to 8&nbsp;years in postmenopausal women with low bone mineral density: a phase 2 study

Rizzoli, René; Benhamou, C.-L.; Halse, J.; Miller, P. D.; Reid, I. R.; Rodríguez Portales, J. A.; DaSilva, C.; Kroon, R.; Verbruggen, N.; Leung, A. T.; Gurner, D.

doi:10.1007/s00198-016-3503-0

Scientific article

English

Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study

ContributorsRizzoli, René; Benhamou, C.-L.; Halse, J.; Miller, P. D.; Reid, I. R.; Rodríguez Portales, J. A.; DaSilva, C.; Kroon, R.; Verbruggen, N.; Leung, A. T.; Gurner, D.

Published inOsteoporosis international, vol. 27, no. 6, p. 2099-2107

Publication date2016

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Génétique des Ostéoporoses (544)

Citation (ISO format)

RIZZOLI, René et al. Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study. In: Osteoporosis international, 2016, vol. 27, n° 6, p. 2099–2107. doi: 10.1007/s00198-016-3503-0

Article (Published version)

Identifiers

PID : unige:85043
DOI : 10.1007/s00198-016-3503-0

Additional URL for this publicationhttp://link.springer.com/10.1007/s00198-016-3503-0

Journal ISSN0937-941X

494views

0downloads

Creation06/27/2016 11:05:00 AM

First validation06/27/2016 11:05:00 AM

Update time03/15/2023 12:31:41 AM

Status update03/15/2023 12:31:41 AM

Last indexation10/31/2024 3:53:28 AM

Archive ouverte UNIGE

Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study

Technical informations